The latest research from ASCO at the Living Room Series
On 15 June the GI Cancer Institute held an instalment of the Living Room Series in Sydney. Two... Read More
AGITG Trial News
AGITG Trial news: The AGITG currently has thirteen studies open to recruitment and four studies in... Read More
Clinical trial offers innovative form of radiotherapy for people with pancreatic cancer
The first Australian clinical trial to use stereotactic body radiotherapy (SBRT) and modern chemotherapy to treat pancreatic cancer... Read More
Trial Updates: September 2019
MONARCC MONARCC is investigating the activity of anti-EGFR monotherapy, or combined with infusional 5FU, in a molecularly selected,... Read More
September 2019: An update from Acting CEO Nisha Berthon-Jones
Dear Members, AGITG CEO, Russell Conley is currently on long service leave, returning in mid-October. As the Acting CEO,... Read More
Why I am leaving a Bequest in my Will
Isabel Kirsh’s decision to leave a bequest to the GI Cancer Institute was a personal one. In 2014,... Read More
One Oesphageal Cancer Survivor’s Experience: Marc Askew shares his story
When Marc Askew first began to experience indigestion and difficulty swallowing, he assumed it was an infection he... Read More
AGITG Outstanding Site Award 2019
Congratulations go to Calvary Mater Newcastle Hospital in New South Wales on being selected to receive the 2019... Read More
Our Gutsy Members
Professor Tim Price, Chair AGITG and Dr Lorraine Chantrill AGITG Director, will each lead a Gutsy Challenge this year to raise funds for the annual AGITG Innovation Fund grant. In September, Dr Lorraine Chantrill will lead a team of Gutsy trekkers as they take on 135kms of the Cape to Cape... Read More
August 2019: An update from CEO Russell Conley
Dear Members, The Annual Scientific Meeting (ASM) has drawn to a close. The meeting was a very positive experience... Read More